相关实验视频

Updated: Feb 28, 2026

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants

Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants

Published on: March 6, 2018

对生物组件的PFDA暴露相关结果的分子和细胞理解

Daisy L Wilson¹, Sayantani Chakraborty², Ummy Habiba Sweety¹

¹Environmental Science and Engineering, The University of Texas at El Paso, El Paso, TX, 79968, USA.

Environmental research

|February 26, 2026

概括

perfluorodecanoic acid (PFDA) 破坏了牛奶蛋白质结构和维生素A的结合,导致模型生物中的神经毒性. 这项研究澄清了PFAS毒性机制,以更好地管理风险.

科学领域:

生物化学生物化学
毒理学毒理学毒理学
分子生物学分子生物学

背景情况:

人类接触表面活性剂 perfluorodecanoic acid (PFDA) 与不良健康影响有关,包括免疫系统功能障碍.
导致PFDA毒性的精确分子机制在很大程度上是未知的.

研究的目的:

为了研究PFDA和牛奶蛋白β-乳糖球蛋白 (BLG) 之间的分子相互作用.
阐明PFDA结合如何影响BLG的功能,特别是其结合视网醇 (维生素A) 的能力.
在模型生物体中探索PFDA暴露的体内影响,Caenorhabditis elegans.

主要方法:

实验室研究检查PFDA对BLG结构和视网醇结合动力学的影响.
计算方法包括对接和分子动力学 (MD) 模拟.
在体内暴露Caenorhabditis elegans的PFDA.

主要成果:

PFDA以剂量依赖的方式扰乱BLG蛋白质结构.
PFDA与BLG (Kd ≈ 3.2 μM) 结合,并显著降低其结合视网醇的能力.
分子模拟显示了PFDA和BLG残留物 (Lys60,Lys69) 之间的特定相互作用 (例如,盐桥形成).
在C. elegans中,PFDA暴露导致了多巴胺能神经元剥离和运动障碍.

结论:

PFDA干扰BLG的结构和功能,损害维生素A的运输.
在体内,PFDA表现出神经毒性作用,突出了其更广泛毒性的潜在机制.
这些发现为PFAS毒性途径提供了洞察力,有助于风险评估和缓解策略.

关键词:

分子建模分子建模 perfluorodecanoic 酸的使用情况蛋白质 - 结构 - 功能

更多相关视频

Integrate Imaging Flow Cytometry and Transcriptomic Profiling to Evaluate Altered Endocytic CD1d Trafficking

Integrate Imaging Flow Cytometry and Transcriptomic Profiling to Evaluate Altered Endocytic CD1d Trafficking

Published on: October 29, 2018

Assessment of the Effects of Endocrine Disrupting Compounds on the Development of Vertebrate Neural Network Function Using Multi-electrode Arrays

Assessment of the Effects of Endocrine Disrupting Compounds on the Development of Vertebrate Neural Network Function Using Multi-electrode Arrays

Published on: April 26, 2018

相关概念视频

Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect

Pharmacokinetic–Pharmacodynamic Relationship: Exposure, Response and Effect

The pharmacokinetic-pharmacodynamic (PK-PD) relationship describes the intricate link between drug exposure, efficacy, and toxicity, forming the foundation for optimal dosing regimens. This relationship uses mathematical modeling to characterize drug concentration-effect dynamics, ensuring precise therapeutic outcomes.Exposure represents the pharmacokinetic aspect of the PK-PD relationship, denoting the drug amount that elicits a biological response. It is typically quantified by administered...